Fertility costs continue to rise, not because of access, but because care decisions happen too late and default too quickly to high-cost pathways like IVF. Leading employers are taking a different approach that improves outcomes while controlling one of the fastest growing areas of healthcare spend.

In this session, Maven product leaders Veronica Venezia, Director of Product, and Jaya Savkar, SVP of Product, will outline how Maven is shifting care earlier in the journey—integrating diagnostics, longitudinal cycle data, and condition-specific pathways for PCOS, endometriosis, and other high-impact conditions to guide more appropriate, cost-effective treatment decisions from the start.

This discussion will focus on what this means for employers, moving from reactive treatment coverage to proactive, clinically managed care with clear financial impact.